Drug intelligence / Profile preview

lidocaine + dexamethasone + honey

Development stage
Preclinical
Lead developer
AstraZeneca
Modality
Implantable Devices → Device-based Delivery → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Inhalation Devices → Device-based Delivery → Drug Delivery Systems
Administration
Topical, Oral
01

Overview

This is a combination formulation containing lidocaine, dexamethasone, and honey. Lidocaine is an amide-type local anesthetic that blocks sodium channels in neuronal membranes, inhibiting nerve impulse conduction and providing local anesthesia. Dexamethasone is a synthetic glucocorticoid corticosteroid with potent anti-inflammatory and immunosuppressant properties; it acts by binding to the glucocorticoid receptor and modulating gene expression to suppress inflammatory mediators. Honey has natural antimicrobial, anti-inflammatory, and wound-healing properties due to its high osmolarity, hydrogen peroxide content, and bioactive compounds. This combination may be used topically or as an oral rinse for symptomatic relief of pain (such as oral mucositis), inflammation reduction, or wound healing in various clinical settings[1][3][6]. The addition of lidocaine provides rapid pain relief through local anesthesia; dexamethasone reduces inflammation; honey supports mucosal healing.

02

Targets

GR (Glucocorticoid receptor)NaV alpha (Voltage-gated sodium channel alpha subunit family)

Beyond the preview

Go deeper on lidocaine + dexamethasone + honey.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lidocaine + dexamethasone + honey.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call